A. Chang

发表

Clinical and Economic Impact of Upfront Next-Generation Sequencing for Metastatic NSCLC in East Asia

Zheng-Yi Zhou, Wenxi Tang, H. Loong, 2022, JTO clinical and research reports.

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Jipan Xie, Zheng-Yi Zhou, Carlos K. H. Wong, 2020, Cost Effectiveness and Resource Allocation.

Cost-effectiveness of ceritinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Jipan Xie, Zheng-Yi Zhou, Carlos K. H. Wong, 2020 .

Respiratory and cardiometabolic comorbidities and Stage I-III non-small cell lung cancer (NSCLC) survival: A pooled analysis from the International Lung Cancer Consortium (ILCCO).

A. Tardón, S. Shete, M. Schabath, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.